SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-088369
Filing Date
2021-07-01
Accepted
2021-07-01 18:14:46
Documents
2
Period of Report
2021-07-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2121105-2_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2121105-2_3seq1.xml 3 1627
2 EXHIBIT 24 tm2121105d2_ex24.htm EX-24 8481
  Complete submission text file 0001104659-21-088369.txt   11569
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Issuer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MOMENTA PHARMACEUTICALS, INC. 675 WEST KENDALL STREET CAMBRIDGE MA 02142
Business Address
Arroyo Santiago (Reporting) CIK: 0001706857 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36576 | Film No.: 211067337